Join to View Full Profile
3601 21st Ave SNashville, TN 37232
Phone+1 404-797-9158
Fax+1 615-936-1812
Dr. Oluwole is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Vanderbilt University Medical CenterFellowship, Hematology and Medical Oncology, 2008 - 2011
Morehouse School of MedicineResidency, Internal Medicine, 2005 - 2008
University of IbadanClass of 1990
Certifications & Licensure
TN State Medical License 2008 - 2025
AL State Medical License 2020 - 2020
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
Clinical Trials
- Cellular Immunotherapy Treatment Antigen-Directed for EBV Lymphoma Start of enrollment: 2014 Sep 01
- CRISPR-Edited Allogeneic Anti-CD19 CAR-T Cell Therapy for Relapsed/Refractory B Cell Non-Hodgkin Lymphoma (ANTLER) Start of enrollment: 2021 May 26
Roles: Contact
Publications & Presentations
PubMed
- Feasibility of axicabtagene ciloleucel in the outpatient setting: primary analysis of prospective trial.Bhagirathbhai Dholaria, Shakthi T Bhaskar, Vivek G Patel, Eden Biltibo, Reena Jayani
Bone Marrow Transplantation. 2025-06-01 - 4 citationsThree-year follow-up analysis of first-line axicabtagene ciloleucel for high-risk large B-cell lymphoma: the ZUMA-12 study.Julio C Chavez, Michael Dickinson, Javier Munoz, Matthew L Ulrickson, Catherine Thieblemont
Blood. 2025-05-15 - Health and Economic Impact of Vein-to-Vein Time in CAR T-Cell Therapy in the Second-Line Treatment of Relapsed/Refractory Large B-Cell Lymphoma: A US Cost-Effectivenes...Olalekan O Oluwole, Markqayne D Ray, Hanxiao Ma, Rishika Sharma, Anik R Patel
Transplantation and Cellular Therapy. 2025-05-13
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
